Generic placeholder image

CNS & Neurological Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5273
ISSN (Online): 1996-3181

Review Article

Designing and Formulation of Nanocarriers for “Alzheimer’s and Parkinson’s” Early Detection and Therapy

Author(s): Jakleen Abujamai, Rukhsana Satar and Shakeel Ahmed Ansari*

Volume 23, Issue 10, 2024

Published on: 13 February, 2024

Page: [1251 - 1262] Pages: 12

DOI: 10.2174/0118715273297024240201055550

Price: $65

Abstract

The potential of nanotechnology in advancing the diagnosis and treatment of neurodegenerative diseases is explored in this comprehensive literature review. The findings of these studies suggest that nanotechnology has the capacity to improve existing therapeutic approaches, create novel and safe compounds, and develop more precise imaging techniques and diagnostic methods for neurodegenerative diseases. With the emergence of the nanomedicine era, a new and innovative approach of diagnosing and treating these conditions has been introduced. Notably, the researchers' development of a nanocarrier drug delivery tool demonstrates immense potential compared to conventional therapy, as it maximizes therapeutic efficacy and minimizes undesirable as side effects.

Keywords: Nanocarriers, neurodegenerative diseases, drug delivery, nanomedicine, diagnostics, blood-brain barrier.


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy